Clinical Trials Logo

Lipoma clinical trials

View clinical trials related to Lipoma.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04236700 Recruiting - Labial Lipoma Clinical Trials

Buccal Evaluation of Mobile Beach Workers

Start date: November 22, 2019
Phase:
Study type: Observational

Tumors in the oral region occur more frequently in men over 40, but can affect people of both gender and all ages, even children. The prevention of oral cancer acquires relevance in public health, particularly if the investigators consider that the preventive approach is compatible with the nature of this disease, as the mouth favors easy visual access. The objective of this study is evaluation the prevalence of oral and perioral injuries in workers who were exposed to the sun on the beaches, investigating possible associations of a sociodemographic, occupational and general health nature.

NCT ID: NCT02722681 Recruiting - Clinical trials for Lipoma of Spinal Cord

Developing a Biomarker for Monitoring Clinical Outcomes in Children With Spinal Lipoma.

Start date: February 2016
Phase: N/A
Study type: Observational

'Spinal lipoma' is a condition, present from before birth, in which fatty tissue (lipoma) is attached to the lower end of the spinal cord, tethering it within the vertebral canal. The cord normally moves up and down with respiration, whereas tethering prevents this movement, and can lead to progressive neurological deterioration. The cord and spinal nerves become stretched and their blood supply is damaged irreversibly. Disability may include weakness or pain in the lower body, and urinary disorders in young children. Treatment is surgical, to remove the lipoma and mobilise the spinal cord, with 60 such operations performed per year at Great Ormond Street Hospital. This project aims to develop lipidomic biomarkers in order to predict which children with spinal lipoma are at highest risk of neurological deterioration, and require early surgery, while providing evidence to adopt a more conservative approach for those at lower risk.